MSI-H Colorectal Carcinoma — Trials

MSI-H Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Emory University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03983993	Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer(NIPAVect)	active not recruiting	Phase 2	26	Emory UniversityOTHER	1	Jan 5, 2026	clinicaltrials
NCT04730544	Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.(NIPISAFE)	active not recruiting	Phase 2	96	GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER